Skip to main content
. 2024 Nov 26;16:795–810. doi: 10.2147/BCTT.S495517

Table 1.

Relationship Between circDOCK1 Expression and Clinicopathologic Features in Patients with HER2+ Breast Cancer No. (%)

Item Total No. circDOCK1 χ 2 p
Low High
Age(years) 0.048 0.84
≤50 42 (41.2) 17 (16.7) 25 (24.5)
>50 60 (58.8) 23 (22.5) 37 (36.1)
Tumor size 0.919 0.631
≤2cm 22 (21.6) 10 (9.8) 12 (11.8)
2–5cm 55 (53.9) 22 (21.6) 33 (32.4)
>5cm 25 (24.5) 8 (7.8) 17 (16.7)
Lymph node status 12.199 0.007
N0 20 (19.6) 14 (13.7) 6 (5.9)
N1 32 (31.4) 13 (12.7) 19 (18.6)
N2 28 (27.5) 6 (5.9) 22 (21.6)
N3 22 (21.6) 7 (6.9) 15 (14.7)
Grade 3.58 0.167
I 30 (29.4) 16 (15.7) 14 (13.7)
II 41 (40.2) 14 (13.7) 27 (26.5)
III 31 (30.4) 10 (9.8) 21 (20.6)
ER status 1.148 0.284
Positive 70 (68.6) 25 (24.5) 45 (44.1)
Negative 32 (31.4) 15 (14.7) 17 (16.7)
PR status 1.316 0.251
Positive 68 (66.7) 24 (23.5) 44 (43.1)
Negative 34 (33.3) 16 (15.7) 18 (17.6)
Ki67 status 1.689 0.194
low 38 (37.3) 18 (17.6) 20 (19.6)
high 64 (62.7) 22 (21.6) 42 (41.2)
Relapse 4.942 0.026
no 87 (85.3) 38 (37.3) 49 (48.0)
yes 15 (14.7) 2 (2.0) 13 (12.7)